Custom fabricated silicone rubber implants for tissue augmentation--a review

Current clinical practices for tissue augmentation rely on a range of implant materials and fabrication techniques. While standard implants offer predictable outcomes, some cases require individualized solutions. Prior research has shown that silicone-based implants can provide durable augmentation in specific anatomical regions. However, no prior work had resolved the long-term outcomes of custom-fabricated silicone implants. This gap motivated the exploration of tailored silicone implants for complex tissue augmentation needs. Custom fabrication introduces variables in material properties and structural integrity. The challenge lies in balancing patient-specific anatomical requirements with material consistency and biocompatibility. No prior work had systematically reviewed the success rates of such implants over extended follow-up periods.

This review aimed to evaluate the clinical outcomes of custom-fabricated silicone rubber implants used for tissue augmentation. The specific problem addressed is the lack of comprehensive data on long-term success and biocompatibility of these implants. The motivation stems from the need to understand how individualized implant design affects patient outcomes. By analyzing a 13-year dataset, the study sought to identify patterns in implant performance. The focus was on the use of 382 RTV silicone elastomer, a material known for its flexibility and durability. The study aimed to determine if custom implants could maintain high success rates over time. It also aimed to assess patient compatibility with these implants. The ultimate goal was to inform clinical decision-making in reconstructive surgery.

The study reviewed 45 silicone rubber implants placed in 44 patients over a 13-year span. All implants were custom-fabricated using 382 RTV silicone elastomer. The implants featured perforations to enhance integration and reduce complications. Data collection included patient records and follow-up assessments. The primary outcome measured was implant success rate. Secondary outcomes included patient compatibility and complication rates. The study design was retrospective, relying on existing clinical documentation. Analysis focused on identifying trends in long-term outcomes and material performance.

The study reported high success rates for custom-fabricated silicone rubber implants. Over 13 years, 45 implants were placed in 44 patients with favorable outcomes. The use of 382 RTV silicone elastomer showed consistent performance across cases. Perforations in the implants were associated with improved integration. No major complications were reported in the reviewed cases. Patient compatibility remained high throughout the follow-up period. The data suggest that custom implants can maintain durability and functionality. These findings support the use of tailored silicone implants in tissue augmentation.

The authors propose that custom-fabricated silicone rubber implants can achieve high success rates in tissue augmentation. The use of 382 RTV silicone elastomer appears to support durable outcomes over extended periods. The study highlights the importance of individualized implant design in reconstructive surgery. Perforations in the implants may enhance integration and reduce complications. The findings suggest that these implants maintain patient compatibility over time. The authors do not claim that custom implants are essential for all cases. They emphasize the need for careful patient selection and material choice. The results support further exploration of tailored implant solutions in clinical practice.